I toksicitetsforsøg med gentagen dosering er anæmi observeret, hvilket sandsynligvis skyldes entakapons jern chelaterende egenskaber.
In repeated dose toxicity studies, anaemia most likely due to iron chelating properties of entacapone was observed.